METHOD OF DIAGNOSIS OF INFLAMMATORY DISEASES USING CALGRANULIN C

    公开(公告)号:CA2474890A1

    公开(公告)日:2003-08-21

    申请号:CA2474890

    申请日:2003-02-17

    Abstract: The present invention is directed to a method for diagnosing inflammatory diseases based on the marker CALGRANULIN C, particularly for diagnosing specific stages of inflammatory diseases and/or for determining the risk of relapse and/or for discriminating between diseases with similar symptoms, sa id method comprising the steps of (a) obtaining a biological sample of mammalia n body fluid or tissue to be diagnosed; (b) determining the amount and/or con~centration of CALGRANULIN C polypeptide and/or nucleic acids encoding th e polypeptide present in said biological sample; and (c) comparing the amount and/or concentration of CALGRANULIN C polypeptide determine in said biologic al sample with the amount and/or concentration of CALGRANULIN C polypeptide as determined in a control sample and/or comparing the amount and/or concentration of nucleic acids encoding CALGRANULIN C polypeptide determined in said biological sample with the amount and/or concentration of nucleic acids encoding CALGRANULIN C polypeptides measured in a control sample, wherein the difference in the amount of CALGRANULIN C polypeptide and/or nucleic acids encoding the polypeptide is indicative for the stages of the disease to be diagnosed.

    Method of diagnosis of inflammatory diseases using calgranulin c

    公开(公告)号:AU2003212245A8

    公开(公告)日:2003-09-04

    申请号:AU2003212245

    申请日:2003-02-17

    Abstract: The present invention is directed to a method for diagnosing inflammatory diseases based on the marker CALGRANULIN C, particularly for diagnosing specific stages of inflammatory diseases and/or for determining the risk of relapse and/or for discriminating between diseases with similar symptoms, said method comprising the steps of (a) obtaining a biological sample of mammalian body fluid or tissue to be diagnosed; (b) determining the amount and/or concentration of CALGRANULIN C polypeptide and/or nucleic acids encoding the polypeptide present in said biological sample; and (c) comparing the amount and/or concentration of CALGRANULIN C polypeptide determine in said biological sample with the amount and/or concentration of CALGRANULIN C polypeptide as determined in a control sample and/or comparing the amount and/or concentration of nucleic acids encoding CALGRANULIN C polypeptide determined in said biological sample with the amount and/or concentration of nucleic acids encoding CALGRANULIN C polypeptides measured in a control sample, wherein the difference in the amount of CALGRANULIN C polypeptide and/or nucleic acids encoding the polypeptide is indicative for the stages of the disease to be diagnosed.

    METHOD OF DIAGNOSIS OF INFLAMMATORY DISEASES USING CALGRANULIN C

    公开(公告)号:AU2003212245A1

    公开(公告)日:2003-09-04

    申请号:AU2003212245

    申请日:2003-02-17

    Abstract: The present invention is directed to a method for diagnosing inflammatory diseases based on the marker CALGRANULIN C, particularly for diagnosing specific stages of inflammatory diseases and/or for determining the risk of relapse and/or for discriminating between diseases with similar symptoms, said method comprising the steps of (a) obtaining a biological sample of mammalian body fluid or tissue to be diagnosed; (b) determining the amount and/or concentration of CALGRANULIN C polypeptide and/or nucleic acids encoding the polypeptide present in said biological sample; and (c) comparing the amount and/or concentration of CALGRANULIN C polypeptide determine in said biological sample with the amount and/or concentration of CALGRANULIN C polypeptide as determined in a control sample and/or comparing the amount and/or concentration of nucleic acids encoding CALGRANULIN C polypeptide determined in said biological sample with the amount and/or concentration of nucleic acids encoding CALGRANULIN C polypeptides measured in a control sample, wherein the difference in the amount of CALGRANULIN C polypeptide and/or nucleic acids encoding the polypeptide is indicative for the stages of the disease to be diagnosed.

    Método de diagnóstico de enfermedades inflamatorias usando calgranulina C

    公开(公告)号:ES2394962T3

    公开(公告)日:2013-02-07

    申请号:ES03708103

    申请日:2003-02-17

    Abstract: Método para el diagnóstico de enfermedades inflamatorias seleccionadas de artritis reumatoide, artritisseronegativa, artritis juvenil y artritis reumatoide juvenil de comienzo sistémico (ARJS), que comprende lasetapas dea) determinar la cantidad y/o concentración de polipéptido de calgranulina C en una muestra de suero de unpaciente; yb) comparar la cantidad y/o concentración de polipéptido de calgranulina C determinada en dicha muestrade suero con la cantidad y/o concentración de polipéptido de calgranulina C determinada en una muestracontrol de suero,en el que un aumento en la cantidad de polipéptido de calgranulina C en la muestra de suero encomparación con la muestra control es indicativo de dicha enfermedad

    Beißring für Endoskopien des oberen Gastrointestinaltraktes

    公开(公告)号:DE102021000985A1

    公开(公告)日:2022-08-25

    申请号:DE102021000985

    申请日:2021-02-24

    Applicant: ROTH JOHANNES

    Inventor: ROTH JOHANNES

    Abstract: Die vorliegende Erfindung betrifft einen Beißring zur Durchführung aller Arten endoskopischer Untersuchungen des oberen Gastrointestinaltraktes mit einem für ein endoskopisches Instrument eine Durchgangsöffnung bietenden Mundstück und den dazugehörigen Haltebögen, dadurch gekennzeichnet, dass die vertikalen Seiten (b) des Mundstückes (a) bei vertikalem Druck komprimierbar sind. Dabei bestehen die Seitenteile (b) aus einer glatten Oberfläche aus thermoplastischem elastomeren Material, so dass keine Reibungsdefekte am Endoskop entstehen. Sind die Seitenteile (b) ziehharmonikaähnlich angeordnet wird medial dieser Seitenteile (b) eine Membran (d), ebenfalls aus einem thermoplastischen elastomeren Material eingefügt, die das Endoskop vor möglichen Reibungsdefekten schützt.

Patent Agency Ranking